Zoetis inc stock.

Stock Information. Stock Quote; Stock Chart; Historical Stock Quote; Investment Calculator; Dividend History; Financials. Quarterly Results; Annual Reports; …The estimated Net Worth of Gregory Norden is at least $9.81 Million dollars as of 17 June 2023. Mr. Norden owns over 14,851 units of Zoetis Inc stock worth over $8,091,578 and over the last 10 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.May 23, 2023 · At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Nov 30, 2023 · Latest news about Zoetis Inc. Transcript : Zoetis Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01:00 PM. Nov. 28. CI. Zoetis Insider Sold Shares Worth $2,298,856, According to a Recent SEC Filing. Nov. 21. MT. Zoetis Insider Sold Shares Worth $163,796, According to a Recent SEC Filing.

Dec 3, 2023 · Get Zoetis Inc (ZTS.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. ... Zoetis Inc. is an animal health company. The Company ... Zoetis' $2 billion acquisition of Abaxis in 2018 was the company's most substantial acquisition, and it also marked the company's entrance into the veterinary diagnostics market. Abaxis provides ...

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies.In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of …See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Charles has made over 17 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Charles sold 42,393 units of ZTS stock worth $1,515,974 on 6 March 2018.Report this job. Posting ID: 875127172 Posted: 2023-11-06 Job Title: Warehouse Associate Forklift. Apply for a Zoetis, Inc Warehouse Associate / Forklift - 1st shift job in Independence, MO. Apply online instantly. View this and more full-time & part-time jobs in Independence, MO on Snagajob. Posting id: 875127172.Lbp Am Sa cut its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 23.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities …We reiterate our Buy rating on Zoetis Inc. stock. While its forecasted annualized return by 2025 year-end is below 10%, this is a resilient business with strong long-term growth potential, ...

Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...

The estimated Net Worth of Paul Bisaro is at least $38.1 million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.

Dec 1, 2023 · Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the third quarter of 2022. The dividend will be paid on Thursday, September 1, 2022, to all holders of record of the Company’s common stock as of the close of business on Thursday, July 21, 2022. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular purpose ...175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 …Real-time Price Updates for Zoetis Inc Cl A (ZTS-N), along with buy or sell indicators, analysis, charts, historical performance, news and moreZoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of …

Current Share Price is $179.13. Zoetis's Dividends per Share for the trailing twelve months (TTM) ended in Today is $1.5.. During the past 13 years, the highest Dividend Yield of Zoetis was 0.98%.The lowest was 0.20%.And the median was 0.62%.. Good Sign: Zoetis Inc stock dividend yield is close to 5-year high. * For Operating Data section: All …Dec 4, 2023 · Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ... Zoetis Inc. (4ZTS.BIT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Borsa Italiana: 4ZTS | Borsa Italiana0.92%. $5.88B. ZTS | Complete Zoetis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nov 22, 2023 · Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.10. The business earned $2.18 billion during the quarter, compared to the consensus estimate of $2.16 billion. 47 minutes ago. Company profile page for Zoetis Inc including stock price, company news, press releases, executives, board members, and contact information.PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies.In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of …

Zacks Equity Research. Zoetis Inc. ZTS reported first-quarter 2023 adjusted earnings (excluding one-time items) of $1.31 per share, which beat the Zacks Consensus Estimate and our model estimates ...Zoetis Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ZTS stock price.

View the latest Zoetis Inc. (ZTS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...The estimated Net Worth of Paul Bisaro is at least $38.1 million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Prior to her executive leadership at Zoetis, Ms. Driscoll served in roles of increasing responsibility at Procter & Gamble from 1994 to 2016. She established and led the company’s global business development group in Geneva, Switzerland, during her tenure as Executive Global Head for Europe, Corporate Global Business Development …Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Forecast. According to 6 analysts, the average rating for ZTS stock is "Strong Buy." The 12-month stock price forecast is $223.0, which is an increase of 24.27% from the latest price.Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...

ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation.

The estimated Net Worth of Catherine A. Knupp is at least $17.1 Millón dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,791,843 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President y President - …

Nov 13, 2023 · Zoetis Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Mexican Stock Exchange: ZTS ... The estimated Net Worth of William C Jr Steere is at least $5.98 Million dollars as of 20 May 2021. Mr. Steere owns over 16,170 units of Zoetis Inc stock worth over $5,651,123 and over the last 20 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc.Real-time Price Updates for Zoetis Inc Cl A (ZTS-N), along with buy or sell indicators, analysis, charts, historical performance, news and more Aug 8, 2023 · Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ... Zoetis Inc (ZTS) stock is trading at $172.42 as of 12:31 PM on Friday, Jul 14, an increase of $1.42, or 0.83% from the previous closing price of $171.00. The stock has traded between $171.12 and $172.90 so far today. Volume today is below average. So far 939,213 shares have traded compared to average volume of 1,815,713 shares. Click Here to ...Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);Zoetis Inc (ZTS) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 🚀 Enjoy a 7-Day Free Trial Thru Dec 07, 2023! Sign Up

For the Zoetis Inc forecast (traded under symbol ZTS) ... Zoetis Inc: Stock buyback: ZTS buyback: Website: www.zoetis.com: Sector: Drugs & Pharmaceuticals: Number of ETFs Holding ZTS: 100 (see which ones) Total Market Value Held by ETFs: $9,326,985,263.3: Total Market Capitalization:Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel TürkiyeBenefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...Instagram:https://instagram. actdxfidelity technology etfcmpx stock forecastmedtronic mdt Zoetis | 394,115 followers on LinkedIn. Nurturing our world and humankind by advancing care for animals | As the world’s leading animal health company, Zoetis is driven by a singular purpose: to ...Get a real-time Zoetis Inc. (ZTS) stock price quote with breaking news, financials, statistics, charts and more. nashville financial plannerowner builder finance At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. micro flipping May 5, 2022 · Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022. Welcome to Zoetis. As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries.